Overview

Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of two dose adjustment regimens (i.e. weight-based and non-weight-based) for the treatment of Chinese hypertensive emergency patients.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma China, Inc.
Treatments:
Nicardipine